Latest Venus Remedies stock price

Venus Remedies P/E Ratio

VENUSREM • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
14.27
Low Valuation
Low - May indicate good value opportunity

Current Valuation Metrics

P/E Ratio 14.27
Current Price ₹691.15
EPS (TTM) ₹33.90
Exchange NSE

Valuation Signal

Signal Fairly Valued
Historical Avg 13.33
Historical Range 6.96 - 18.69
Percentile 50.0%

Sector Context

Sector Average 57.81
Sector Median 36.22
Sector Rank #7 of 88
Sector Percentile 8.0%

Earnings Breakdown (TTM)

TTM EPS ₹40.58
Sept 2025 ₹15.06
Mar 2025 ₹15.71

Key P/E Ratio Insights for Venus Remedies

  • Stock appears undervalued with PE of 14.27, suggesting potential buying opportunity
  • Trading at discount to sector average PE of 57.81

View the VENUSREM equity price for detailed stock performance.

P/E Ratio Historical Trend for Venus Remedies

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 12.28 26.07 ₹320.15 BSE Low
2023 18.69 21.72 ₹405.95 BSE Moderate
2022 15.38 11.78 ₹181.15 BSE Moderate
2021 6.96 58.85 ₹409.60 BSE Low

Sector P/E Ratio Comparison

Comparing Venus Remedies with other companies in Healthcare sector
Sector Average
57.81
Sector Median
36.22
Lowest P/E
9.01
Highest P/E
515.32
Companies
88
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low
Lincoln Pharmaceuticals LINCOLN 12.02 ₹974 Low
QMS Medical Allied Servi… QMSMEDI 12.82 ₹177 Low
Take Solutions TAKE 13.15 ₹638 Low
Royal Sense ROYAL 14.5 ₹96 Low
Bliss GVS Pharma BLISSGVS 16.62 ₹1,973 Moderate
RPG Life Sciences RPGLIFE 17.94 ₹3,861 Moderate
Gennex Laboratories GENNEX 17.99 ₹329 Moderate